Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU)

Antiviral Research

Volumn 29, Issue 2-3, 1996, Pages 125-139

  Colacino, Joseph M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

fialuridine; FIAU; hepatitis B; mitochondrial toxicity

Indexed keywords

1 (2 DEOXY 2 FLUORO 1 BETA DEXTRO ARABINOFURANOSYL 5 IODO) CYTOSINE; DNA DIRECTED DNA POLYMERASE GAMMA; FIALURIDINE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CHRONIC HEPATITIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; HEPATITIS B; HEPATITIS B VIRUS; HERPES VIRUS; HUMAN; HYPOTHESIS; LACTIC ACIDOSIS; LONG TERM CARE; MULTIPLE ORGAN FAILURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

HEPATITIS B VIRUS; HERPES; HERPESVIRIDAE;

EID: 0029866581     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00836-5     Document Type: Review

References (66)

1. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R.J., Rahmsdorf, H.J., Jonat, C., Herrlich, P. and Karin, M. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729-739.
2. Arnaudo, E., Dalakas, M., Shanske, S., Moraes, C.T., DiMauro, S. and Schon, E.A. (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337, 508-510.
3. Bergstrom, D.E. and Swartling, D.J. (1988) In: J.F. Liebman, A. Greenberg and W.R. Dolbier (Eds), Fluorine-containing molecules: structure, reactivity, synthesis, and applications. VCH, New York.
4. Bowsher, R.R., Compton, J.A., Kirkwood, J.A., Place, G.D., Jones, C.D., Mabry, T.E., Hyslop, D.L., Hatcher, B.L. and DeSante, K.A. (1994) Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers. Antimicrob. Agents Chemother. 38, 2134-2142.
5. Braun, T.J., Feinberg, A., Chou, T.-C., Watanabe, K.A., Matsuda, A., Fox, J.J. and Philips, F.S. (1982) Thymidylate synthetase (TS) and the metabolism of 2′-fluoro-5-iodo-ara-C (FIAC). Proc. Am. Assoc. Cancer Res. 23, 213.
6. Chen, C.-H. and Cheng, Y.-C. (1989) Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J. Biol. Chem. 264, 11934-11937.
7. Chen, C.-H. and Cheng, Y.-C. (1992) The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J. Biol. Chem. 267, 2856-2859.
8. Chen, M.S., Van Nostrand, M. and Oshana, S.C. (1986) Quantitative determination of antiviral nucleoside analog in DNA. Anal. Biochem. 156, 300-304.
9. Cheng, Y.-C., Dutschman, G., Fox, J.J., Watanabe, K.A. and Machida, H. (1981) Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob. Agents Chemother. 20, 420-423.
10. Cherrington, J.M., Allen, S.J., McKee, B.H. and Chen, M.S. (1994) Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma. Biochem. Pharmacol. 48, 1986-1988.
11. Chirgwin, J.J., Przbyla, A.E., MacDonald, R.J. and Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
12. Chou, T.-C., Feinberg, A., Grant, A.J., Vidai, P., Reichman, U., Watanabe, K.A., Fox, J.J. and Philips, F.S. (1981) Pharmacological disposition and metabolic fate of 2′-fluoro-5-iodo-1-β-D-arabinofuranosylcytosine in mice and rats. Cancer Res. 41, 3336-3342.
13. Chou, T.-C., Lopez, C., Colacino, J.M., Grant, A., Feinberg, A., Su, T.-L., Watanabe, K.A., Fox, J.J. and Philips, F.S. (1983) Mechanism of antiviral action of 2′-fluoro-arabinosyl pyrimidine nucleosides. Proc. Am. Assoc. Cancer Res. 24, 1205.
14. Chou, T.-C., Kong, X.-B., Fanucchi, M.P., Cheng, Y.-C., Takahashi, K., Watanabe, K.A. and Fox, J.J. (1987) Synthesis and biological effects of 2′-fluoro-5-ethyl-1-β-arabinofuranosyluracil. Antimicrob. Agents Chemother. 31, 1355-1358.
15. Colacino, J. and Lopez, C. (1983) Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents. Antimicrob. Agents Chemother. 25, 505-508.
16. Colacino, J.M., Malcolm, S.K. and Jaskunas, S.R. (1994) Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture. Antimicrob. Agents Chemother. 38, 1997-2002.
17. Cui, L., Yoon, S., Schinazi, R.F. and Sommadossi, J.-P. (1995) Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-β-D-arabinofuranosyl)-5-iodouracil in human liver cells. J. Clin. Invest. 95, 555-563.
18. Dalakas, M., Illa, I., Pezeshkpour, G.H., Laukaitis, J.P., Cohen, B. and Griffin, J.L. (1990) Mitochondrial myopathy caused by long-term AZT (zidovudine) therapy: management and differences from HIV-associated myopathy. N. Engl. J. Med. 322, 1098-1105.
19. Daluge, S.M., Purifoy, D.M., Savina, P.M., St. Clair, M.H., Parry, N.R., Dev, I.K., Novak, P., Ayers, K.M., Reardon, J.E., Roberts, G.B., Fyfe, J.A., Blum, M.R., Averett, D.R., Dornsife, R.E., Domin, B.A., Ferone, R., Lewis, D.A. and Krenitsky, T.A. (1994) 5-chloro-2′,3′-dideoxy-3-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile. Antimicrob. Agents Chemother. 38, 1590-1603.
20. Dubinsky, R.M., Yarchoan, R., Dalakas, M. and Broder, S. (1989) Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′-dideoxycytidine (ddC). Muscle Nerve 12, 856-860.
21. Flint, O.P. (1994) In vitro studies of the toxicity of nucleoside analogues used in the treatment of HIV infection. Toxic. In Vitro. 8, 677-683.
22. Fourel, I., Hantz, O., Cova, L., Allaudeen, H.S. and Trepo, C. (1990) Inhibitory effects of 2′-fluoro arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks. Antimicrob. Agents Chemother. 34, 473-475.
23. Fourel, I., Li, J., Hantz, O., Jacquet, C., Fox, J.J. and Trepo, C. (1992) Effects of 2′-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks. J. Med. Virol. 37, 122-126.
24. Fried, M.W., DiBisceglie, A.M., Straus, S.E., Savarese, B., Beames, M.P. and Hoofnagle, J.H. (1992) FIAU, a new oral anti-viral agent, profoundly inhibits HBV DNA in patients with chronic hepatitis B. Hepatology 16, 127a.
25. Garrett, C., Wataya, Y. and Santi, D.V. (1979) Thymidylate synthetase. Catalysis of dehalogenation of 5-bromo-and 5-iodo-2′-deoxyuridylate. Biochemistry 18, 2798-2804.
26. Gertner, E., Thurn, J.R., Williams, D.N., Simpson, M., Balfour, H.H., Rhame, F. and Henry, K. (1989) Zidovudine-associated myopathy. Am. J. Med. 86, 814-818.
27. Grant, A.J., Feinberg, A., Chou, T.-C, Watanabe, K.A., Fox, J.J. and Philips, F.S. (1982) Incorporation of the metabolites of 2′-fluoro-5-iodo-1-β-D-arabinofuranosylcytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissues. Biochem. Pharmacol. 31, 1103-1108.
28. Hantz, O., Allaudeen, H.S., Ooka, T., De Clercq, E. and Trepo, C. (1984) Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2′-deoxyuridine. Antiviral Res. 4, 187-199.
29. Hart, G.J., Orr, D.C., Penn, C.R., Figueiredo, H.T., Gray, N.M., Boehme, R.E. and Cameron, J.M. (1992) Effects of (-)-2′-deoxy-3′-thiacytidine (3TC) 5′-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma. Antimicrob. Agents Chemother. 36, 1688-1694.
30. Huang, P., Chubb, S. and Plunkett, W. (1990) Termination of DNA synthesis by 9-β-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity. J. Biol. Chem. 265, 16617-16625.
31. Jaffe, H.S. (1994) Clinical trials of (S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine (HPMPC). Antiviral Res. 23 (Suppl. 1), 43.
32. Jossee, A., Kaiser, A.D. and Kornberg, A. (1961) Enzymatic synthesis of deoxyribonucleic acid. VIII. Frequencies of nearest neighbor base sequences in deoxyribonucleic acid. J. Biol. Chem. 236, 864-875.
33. Klecker, R.W., Katki, A.G. and Collins, J.M. (1994) Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2′-fluoro-2′-deoxy-β-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells. Mol. Pharmac. 46, 1204-1209.
34. Korba, B.E. and Gerin, J.L. (1992) Use of a standardized cell culture assay to assess the activities of nucleoside analogs against hepatitis B virus replication. Antiviral Res. 19, 55-70.
35. Kreis, W., Damin, L., Colacino, J. and Lopez, C. (1982) In vitro metabolism of 1-β-D-arabinofuranosylcytosine and 1-β-D-2′-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells. Biochem. Pharmacol. 31, 767-773.
36. Kufe, D.W., Major, P.P., Egan, E.M. and Beardsley, G.P. (1980) Correlation of cytotoxicity with incorporation of ara-C into DNA. J. Biol. Chem. 255, 8997-9000.
37. Lamperth, L., Dalakas, M.C., Dagani, F., Anderson, J. and Ferrari, R. (1991) Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab. Invest. 65, 742-751.
38. Lee, W., Mitchell, P. and Tjian, R. (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752.
39. Lewis, W., Papoian, T., Gonzalez, B., Louie, H., Kelly, D.P., Payne, R.M. and Grody, W.W. (1991) Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab. Invest. 65, 228-236.
40. Lewis, W., Gonzalez, B., Chomyn, A. and Papoian, T. (1992) Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal and muscle mitochondria. J. Clin. Invest. 89, 1354-1360.
41. Lewis, W., Simpson, J.F. and Meyer, R.R. (1994a) Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and non-competitively by phosphorylated zidovudine. Circ. Res. 74, 344-348.
42. Lewis, W., Meyer, R.R., Simpson, J.F., Colacino, J.M. and Perrino, F.W. (1994b) Mammalian DNA polymerases a, b, g, d, and e incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU triphosphate. Biochemistry 33, 14620-14624.
43. Lewis, W. and Dalakas, M.C. (1995) Mitochondrial toxicity of antiviral drugs. Nature Med. 1, 417-422.
44. Lin, J.-C. Smith, M.C. and Cheng, Y.-C. (1983) Epstein-Barr virus: Inhibition of replication by three new drugs. Science 221, 578-579.
45. Löfgren, B., Habteyesus, A., Nordenfelt, E., Eriksson, S. and Öberg, B. (1990) Inefficient phosphorylation of 3′-fluoro-2′-dideoxythymidine in liver cells may explain its lack of inhibition of duck hepatitis B virus in vivo. Antiviral Chem. Chemother. 1, 361-366.
46. Lopez, C., Watanabe, K.A. and Fox, J.J. (1980) 2′-fluoro-5-iodoaracytosine, a potent and selective anti-herpesvirus agent. Antimicrob. Agents Chemother. 17, 803-806.
47. Martin, J.L., Brown, C.E., Matthews-Davis, N. and Reardon, J.E. (1994) Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob. Agents Chemother. 38, 2743-2749.
48. McKenzie, R., Fried, M.W., Sallie, R., Conjeevaram, H., Di Bisceglie, A.M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., Pruett, T., Stotka, J.L., Straus, S.E. and Hoofnagle, J.H. (1995) Hepatic failure and lactic acidosis due to Fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N. Engl. J. Med. 333, 1099-1105.
49. Medina, D.J., Tsai, C.-H., Hsiung, G.D. and Cheng, Y.-C. (1994) Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrob. Agents Chemother. 38, 1824-1828.
50. Mhiri, C., Baudrimont, M., Bonne, G., Geny, C., Degoul, F., Marsac, C., Roullet, E. and Gherardi, R. (1991) Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction. Ann. Neurol. 29, 606-614.
51. Müller, W.E.G., Rhode, H.J., Beyer, R., Maidhof, A., Lachman, M., Taschner, H. and Zahn, R.K. (1975) Mode of action of 9-β-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro. Cancer Res. 35, 2160-2168.
52. Parker, W.B. and Cheng, Y.-C. (1994) Mitochondrial toxicity of antiviral nucleoside analogs. J. NIH Res. 5, 33-35.
53. Reardon, J.E. (1989) Herpes simplex virus type 1 and human DNA polymerase interactions with 2′-deoxyguanosine 5′-triphosphate analogues. J. Biol. Chem. 264, 19039-19044.
54. Richardson, F.C., Engelhardt, J.A. and Bowsher, R.R. (1994) Fialuridine accumulates in DNA of dogs, monkeys, and rats following long-term oral administration. Proc. Natl. Acad. Sci. USA 91, 12003-12007.
55. Risse, J., Jooss, K., Neuberg, M., Brüller, H.-J. and Müller, R. (1989) Asymmetrical recognition of the palindromic API binding site (TRE) by Fos protein complexes. EMBO J. 8, 3825-3832.
56. Schat, K.A., Schinazi, R.F. and Calnek, B.W. (1984) Cell-specific antiviral activity of 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine (FIAC) against Marek's disease herpesvirus and turkey herpesvirus. Antiviral Res. 4, 259-270.
57. Schilke, A.J., Staschke, K.A. and Colacino, J.M. (1994) Inhibition of duck hepatitis B virus DNA polymerase by the triphosphate of fialuridine. Antiviral Res. 23 (Suppl 1), 80.
58. Schinazi, R.F., Fox, J.J., Watanabe, K.A. and Nahmias, A.J. (1986) Activities of 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2. Antimicrob. Agents Chemother. 29, 77-84.
59. Staschke, K.A., Colacino, J.M., Mabry, T.E. and Jones, C.D. (1994) The in vitro anti-hepatitis B virus activity of FIAU [1-(2′-deoxy-2′-fluoro-1-β-D-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cell. Antiviral Res. 23, 45-61.
60. Staschke, K.A. and Colacino, J.M. (1994) Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5′-triphosphate of fialuridine. J. Virol. 68, 8265-8269.
61. Stevenson, W., Gaffey, M., Ishitani, M., McCullough, C., Dickson, R., Caldwell, S., Lobo, P. and Pruett, T. (1995) Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection. Transplant. Proc. 27, 1219-1221.
62. Stryer, L. (1988) Biochemistry. 3rd Edition. W.H. Freeman and Co., New York.
63. Tamura, K. and Aotsuka, T. (1988) Rapid isolation method of animal mitochondrial DNA by the alkaline lysis procedure. Biochem. Genet. 26, 815-819.
64. van Leeuwen, R., Katlama, C., Kitchen, V., Boucher, C.A., Tubiana, R., McBride, M., Ingrand, D., Weber, J., Hill, A., McDade, H. and Danner, S.A. (1995) Evaluation of safety and efficacy of 3TC (Lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: A phase I/II study. J. Infect. Dis. 171, 1166-1171.
65. Wang, G.-H. and Seeger, C. (1992) The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71, 663-670.
66. Wang, G.-H. and Seeger, C. (1993) Novel mechanism for reverse transcription in hepatitis B viruses. J. Virol. 67, 6507-6512.